Sabin works with partners around the world, including the World Health Organization (WHO), the Pan American Health Organization (PAHO), Fundação Oswaldo Cruz (FIOCRUZ) and the Bill & Melinda Gates Foundation, to convene symposiums that have brought together more than 2,400 of the world’s global health stakeholders to work on advancing vaccination as a cost-effective weapon in public health.
Sabin is dedicated to reducing the burden and impact of infectious diseases through the use of new and underutilized vaccines. In addition to the Coalition against Typhoid (CaT) Secretariat, the International Association of Immunization Managers (IAIM), ProVac International Working Group (IWG) and the Sustainable Immunization Financing (SIF) program, Sabin also works on policy, research and other initiatives focusing on a number of issues from meningococcal disease burden to dengue vaccine preparedness. 
Sabin provides decision makers with the information and resources needed to introduce and sustain immunization programs against a range of diseases. These projects bring together policymakers, researchers, industry representatives, public health officials, health care professionals and others to share the latest research on diseases and solutions, discuss strategies for reducing global disease burdens, and develop and implement sustainable vaccination programs.

Human Papillomavirus (HPV)
Rubella and CRS